Financials in USD. Standardized financial statements.
A compact view of how Embla Medical hf. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $963.59M | $854.89M | $785.68M | $718.65M | $718.67M | $629.50M | $686.26M | $612.88M | $568.62M | $520.75M |
| Revenue Growth? | +12.7% | +8.8% | +9.3% | -0.0% | +14.2% | -8.3% | +12.0% | +7.8% | +9.2% | 0.0% |
| Cost of Revenue? | $403.00M | $320.19M | $300.11M | $278.90M | $263.28M | $238.27M | $247.61M | $226.07M | $213.83M | $192.31M |
| Gross Profit? | $560.59M | $534.70M | $485.57M | $439.75M | $455.39M | $391.24M | $438.65M | $386.80M | $354.79M | $328.44M |
| Gross Margin? | +58.2% | +62.5% | +61.8% | +61.2% | +63.4% | +62.1% | +63.9% | +63.1% | +62.4% | +63.1% |
| Operating Expenses? | $431.21M | $421.95M | $396.19M | $372.61M | $359.76M | $337.97M | $341.12M | $303.79M | $279.93M | $256.42M |
| Operating Income? | $129.38M | $112.75M | $89.39M | $64.84M | $97.31M | $22.33M | $98.60M | $78.92M | $74.82M | $72.17M |
| EBITDA? | $189.89M | $169.78M | $146.14M | $119.99M | $144.77M | $87.03M | $143.99M | $118.51M | $101.19M | $90.88M |
| Income Before Tax | $111.99M | $90.56M | $76.01M | $56.17M | $86.64M | $12.72M | $90.27M | $96.92M | $68.74M | $68.42M |
| Income Tax Expense | $25.20M | $21.60M | $17.21M | $12.96M | $20.98M | $4.80M | $21.39M | $17.10M | $11.08M | $17.42M |
| Net Income? | $86.47M | $68.28M | $58.39M | $42.51M | $63.99M | $6.21M | $66.04M | $79.75M | $57.65M | $51.03M |
| EPS? | $0.20 | $0.16 | $0.14 | $0.10 | $0.15 | $0.02 | $0.16 | $0.19 | $0.13 | $0.12 |
| Diluted EPS? | $0.20 | $0.16 | $0.14 | $0.10 | $0.15 | $0.02 | $0.16 | $0.19 | $0.13 | $0.12 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality